MANGALAM DRUGS & ORGANICS LTD. - 532637 - Intimation Of The Board Meeting Scheduled To Be Held On Monday, August 10, 2020 Inter-Alia To Consider & Approve The Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2020.
Intimation of the Board Meeting scheduled to be held on Monday, August 10, 2020 inter-alia to consider & approve the un-audited financial results of the Company for the quarter ended June 30, 2020. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Related Party Transactions_Compliance under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2020. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholding for the Period Ended June 30, 2020
Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1010 Name of the Signatory :- GEETA KARIRADesignation :- Company Secretary and Compliance Officer MANGALAM DRUGS & ORGANICS LTD. - 532637 - General Update - Non - Applicability Of Large Corporate Framework Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26,2018.
Declaration with respect to Non - Applicability of Large Corporate Framework pursuant to SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26,2018. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window
Closure of Trading Window MANGALAM DRUGS & ORGANICS LTD. - 532637 - Standalone Audited Financial Results For The Quarter And Year Ended March 31, 2020.
In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we have to inform you that the Board of Directors of the Company, in their meeting held today i.e. Monday, June 29, 2020 has inter-alia approved the Audited Financial Results (Standalone) for the quarter and year ended March 31, 2020 pursuant to Regulation 33 of the Listing Regulations. A copy of the said results, notes thereto and Auditor's Report is enclosed for your records. We hereby declare that the Auditors have expressed an unmodified opinion in the Audit Report on the Standalone Audited Financial Results for the quarter and year ended March 31, 2020. The meeting of Board of Directors of the Company commenced at 3:00 P.M. and concluded at 4:50 P.M. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Outcome Of The Board Meeting Held On June 29, 2020.
In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we have to inform you that the Board of Directors of the Company, in their meeting held today i.e. Monday, June 29, 2020 has inter-alia approved the Audited Financial Results (Standalone) for the quarter and year ended March 31, 2020 pursuant to Regulation 33 of the Listing Regulations. A copy of the said results, notes thereto and Auditor's Report is enclosed for your records. We hereby declare that the Auditors have expressed an unmodified opinion in the Audit Report on the Standalone Audited Financial Results for the quarter and year ended March 31, 2020. The meeting of Board of Directors of the Company commenced at 3:00 P.M. and concluded at 4:50 P.M.
